Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Apr 22, 2025 | Returns since inception | ET Money Rank | VRO Ratings |
---|---|---|---|
₹478.3685+0.75% 1 day change | 18.33% p.a. | 5 |
VRO rating | 5 |
Expense ratio | 0.9% as on Mar 31, 2025 |
Exit load | 0.5% Exit load of 0.50% if redeemed within 15 days! |
AUM (Fund size) | ₹3,611 Crs |
Lock-in | No Lockin |
Age | 12 yrs 3 m since Jan 01, 2013 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP ₹500 & Lump. ₹5000 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, pay tax of 12.5% on returns of ₹1.25 lakh+ in a financial year |
Period | This fund | Category average |
---|---|---|
1 month | 0.06% | 0.8% |
3 months | 1.6% | 0.61% |
6 months | 2.93% | -1.43% |
1 year | 23.15% | 21.96% |
3 years | 25.24% | 22.2% |
5 years | 25.94% | 23.82% |
7 years | 20.41% | 20.19% |
10 years | 13.32% | 13.65% |
Large Cap 31.298697%
Mid Cap 28.710666%
Small Cap 36.920637000000006%
Other Cap 0.0%
Healthcare 93.71000000000001%
Chemicals 3.22%
Bifurcation by Credit Quality is not available for this fund
Reserve Bank of India 0.08%
ADS/ADR 4.38%
Repo 3.16%
Treasury Bills 0.08%
Others 3.16%
Fund name | ETM Rank | AUM (in Crs.) | Fund age | Expense ratio |
---|---|---|---|---|
SBI Healthcare Opportunities Fund | N.A. | ₹3,611 Crs | 12 yrs 3 m | 0.9% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | ₹4,915 Crs | 6 yrs 9 m | 1.18% |
DSP Healthcare Fund | N.A. | ₹3,019 Crs | 6 yrs 5 m | 0.63% |
Tata India Pharma & HealthCare Fund | N.A. | ₹1,184 Crs | 9 yrs 4 m | 0.72% |
Mirae Asset Healthcare Fund | N.A. | ₹2,667 Crs | 6 yrs 10 m | 0.61% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund | 0.06% | 2.93% | 23.15% | 25.24% | 25.94% | 13.32% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 1.25% | -0.91% | 25.04% | 25.89% | 26.38% | 15.1% |
DSP Healthcare Fund | -1.44% | -5.28% | 18.69% | 22.05% | 26.08% | 15.24% |
Tata India Pharma & HealthCare Fund | 1.88% | -1.7% | 21.43% | 22.65% | 23.83% | 13.09% |
Mirae Asset Healthcare Fund | 0.52% | -1.7% | 22.46% | 20.85% | 24.59% | 15.25% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
SBI Healthcare Opportunities Fund | 14.93 | 0.85 | 1.12 | 1.65 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 16.26 | 0.93 | 1.01 | 1.61 |
DSP Healthcare Fund | 15.95 | 0.87 | 0.91 | 1.56 |
Tata India Pharma & HealthCare Fund | 16.85 | 0.96 | 0.82 | 1.36 |
Mirae Asset Healthcare Fund | 17.14 | 0.98 | 0.77 | 1.27 |
Alpha | 5.05 vs. 3.94 Higher outperformance against benchmark |
Sharpe | 1.12 vs. 4.28 Poor risk-adjusted returns |
Beta | 0.85 vs. 0.75 More sensitive to market's ups & downs |
Standard deviation | 14.93 vs. 10.22 More volatile performance |
Fund AUM | ₹3,611 Crs as on Mar 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
No. of schemes | 67 view all schemes |
Total AUM | ₹10,76,364 Crs as on Mar 31, 2025 |
Address | 9th Floor-Crescenzo, C-38 & 39- G Block, Bandra-Kurla Complex, Bandra (East) Mumbai, 400051 |
Phone | 022-61793000 / 1800-425-5425 |
Fund name | ETM Rank | AUM (in Crs.) | 1Y | 5Y |
---|---|---|---|---|
SBI Contra Fund | N.A. | ₹42,220 Crs | 6.43% | 37.03% |
SBI Magnum Midcap Fund | N.A. | ₹20,890 Crs | 10.29% | 33.52% |
SBI PSU Fund | N.A. | ₹4,789 Crs | 3.99% | 33.36% |
SBI Infrastructure Fund | N.A. | ₹4,681 Crs | 1.61% | 32.49% |
SBI Small Cap Fund | N.A. | ₹30,829 Crs | 4.43% | 31.39% |
SBI Long Term Equity Fund | N.A. | ₹27,730 Crs | 9.87% | 30.71% |
The current Net Asset Value (NAV) of the SBI Healthcare Opportunities Fund - Direct Growth plan is approximately ₹478.3685 as of Apr 22, 2025.
The SBI Healthcare Opportunities Fund is a 12 yrs 3 m old fund and has delivered average annual returns of 18.33% since inception.
1-Year | 3-Year | 5-Year | 10-Year | Since Inception |
---|---|---|---|---|
23.15% | 25.24% | 25.94% | 13.32% | 18.33% |
The SBI Healthcare Opportunities Fund - Direct Growth has an expense ratio of 0.9%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The SBI Healthcare Opportunities Fund currently has assets under management (AUM) or fund size valued at approximately ₹3,611 Crs crore as of Mar 31, 2025.
The SBI Healthcare Opportunities Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.45% |
Max Healthcare Institute Ltd. | 6.68% |
Divi's Laboratories Ltd. | 6.0% |
Cipla Ltd. | 4.79% |
Lupin Ltd. | 4.72% |
Lonza Group Ag | 4.38% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.72% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Ami Organics Ltd. | 3.38% |
The SBI Healthcare Opportunities Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 93.71000000000001% |
Chemicals | 3.22% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in SBI Healthcare Opportunities Fund is complete.
Redeeming your investments in SBI Healthcare Opportunities Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in SBI Healthcare Opportunities Fund from anywhere else, you can go to the fund house website and put a request through it.